This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


4lp0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:21, 1 March 2024) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Crystal structure of a topoisomerase ATP inhibitor==
==Crystal structure of a topoisomerase ATP inhibitor==
-
<StructureSection load='4lp0' size='340' side='right' caption='[[4lp0]], [[Resolution|resolution]] 1.95&Aring;' scene=''>
+
<StructureSection load='4lp0' size='340' side='right'caption='[[4lp0]], [[Resolution|resolution]] 1.95&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4lp0]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Strr6 Strr6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LP0 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4LP0 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4lp0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_pneumoniae_R6 Streptococcus pneumoniae R6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LP0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LP0 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1YM:6-[(ETHYLCARBAMOYL)AMINO]-4-[4-(TRIFLUOROMETHYL)-1,3-THIAZOL-2-YL]-3,3-BIPYRIDINE-5-CARBOXYLIC+ACID'>1YM</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.95&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4lpb|4lpb]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1YM:6-[(ETHYLCARBAMOYL)AMINO]-4-[4-(TRIFLUOROMETHYL)-1,3-THIAZOL-2-YL]-3,3-BIPYRIDINE-5-CARBOXYLIC+ACID'>1YM</scene></td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">parE, spr0756 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=171101 STRR6])</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lp0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lp0 OCA], [https://pdbe.org/4lp0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lp0 RCSB], [https://www.ebi.ac.uk/pdbsum/4lp0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lp0 ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lp0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lp0 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lp0 RCSB], [http://www.ebi.ac.uk/pdbsum/4lp0 PDBsum]</span></td></tr>
+
</table>
</table>
-
<div style="background-color:#fffaf0;">
+
== Function ==
-
== Publication Abstract from PubMed ==
+
[https://www.uniprot.org/uniprot/Q8DQB5_STRR6 Q8DQB5_STRR6]
-
The discovery and optimization of a new class of bacterial topoisomerase (DNA gyrase and topoisomerase IV) inhibitors binding in the ATP domain are described. A fragment molecule, 1-ethyl-3-(2-pyridyl)urea, provided sufficiently potent enzyme inhibition (32 muM) to prompt further analogue work. Acids and acid isosteres were incorporated at the 5-pyridyl position of this fragment, bridging to a key asparagine residue, improving enzyme inhibition, and leading to measurable antibacterial activity. A CF3-thiazole substituent at the 4-pyridyl position improved inhibitory potency due to a favorable lipophilic interaction. Promising antibacterial activity was seen versus the Gram-positive pathogens Staphylococcus aureus and Streptococcus pneumoniae and the Gram-negative pathogens Haemophilus influenzae and Moraxella catarrhalis . Precursor metabolite incorporation and mutant analysis studies support the mode-of-action, blockage of DNA synthesis by dual target topoisomerase inhibition. Compound 35 was efficacious in a mouse S. aureus disease model, where a 4.5-log reduction in colony forming units versus control was demonstrated.
+
-
 
+
-
Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents.,Basarab GS, Manchester JI, Bist S, Boriack-Sjodin PA, Dangel B, Illingworth R, Sherer BA, Sriram S, Uria-Nickelsen M, Eakin AE J Med Chem. 2013 Oct 29. PMID:24098982<ref>PMID:24098982</ref>
+
-
 
+
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+
-
</div>
+
==See Also==
==See Also==
-
*[[Topoisomerase|Topoisomerase]]
+
*[[Topoisomerase 3D structures|Topoisomerase 3D structures]]
-
== References ==
+
-
<references/>
+
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Strr6]]
+
[[Category: Large Structures]]
-
[[Category: Basarab, G S]]
+
[[Category: Streptococcus pneumoniae R6]]
-
[[Category: Bist, S]]
+
[[Category: Basarab GS]]
-
[[Category: Boriack-Sjodin, P A]]
+
[[Category: Bist S]]
-
[[Category: Dangel, B]]
+
[[Category: Boriack-Sjodin PA]]
-
[[Category: Eakin, A E]]
+
[[Category: Dangel B]]
-
[[Category: Illingsworth, R]]
+
[[Category: Eakin AE]]
-
[[Category: Manchester, J I]]
+
[[Category: Illingsworth R]]
-
[[Category: Sherer, B A]]
+
[[Category: Manchester JI]]
-
[[Category: Sriram, S]]
+
[[Category: Sherer BA]]
-
[[Category: Uria-Nickelsen, M]]
+
[[Category: Sriram S]]
-
[[Category: Antimicrobial]]
+
[[Category: Uria-Nickelsen M]]
-
[[Category: Atp binding]]
+
-
[[Category: Atpase domain]]
+
-
[[Category: Isomerase-isomerase inhibitor complex]]
+
-
[[Category: Protein-inhibitor complex]]
+
-
[[Category: Structure-based drug design]]
+
-
[[Category: Virtual screen]]
+

Current revision

Crystal structure of a topoisomerase ATP inhibitor

PDB ID 4lp0

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4lp0"
Personal tools